Table 2.

All grade II adverse events and any grade I adverse events occurring in more than 1 patient (n = 14)

Toxicity	Grade I (%)	Grade II (%)
Reduced hemoglobin	3 (21)	0
Rash	2 (14)	0
Fatigue	0	1 (7)
Diarrhea	2 (14)	0
Nausea and vomiting	0	1 (7)
Dizziness	0	1 (7)
Headache	7 (50)	0
Elevation in triglycerides	2 (14)	0
Elevation in cholesterol	3 (21)	0
Nasal congestion	2 (14)	0
Decreased anion gap	2 (14)	0
Elevated chloride	2 (14)	0